{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:14:02Z","timestamp":1722888842359},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T00:00:00Z","timestamp":1444608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00277-015-2515-8","type":"journal-article","created":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T21:07:47Z","timestamp":1444684067000},"page":"93-103","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials"],"prefix":"10.1007","volume":"95","author":[{"name":"on behalf of the Children\u2019s Leukemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC)","sequence":"first","affiliation":[]},{"given":"Pauline","family":"Simon","sequence":"first","affiliation":[]},{"given":"Stefan","family":"Suciu","sequence":"additional","affiliation":[]},{"given":"Emmanuelle","family":"Clappier","sequence":"additional","affiliation":[]},{"given":"H\u00e9l\u00e8ne","family":"Cave","sequence":"additional","affiliation":[]},{"given":"Nicolas","family":"Sirvent","sequence":"additional","affiliation":[]},{"given":"Genevi\u00e8ve","family":"Plat","sequence":"additional","affiliation":[]},{"given":"Antoine","family":"Thyss","sequence":"additional","affiliation":[]},{"given":"Fran\u00e7oise","family":"Mechinaud","sequence":"additional","affiliation":[]},{"given":"Vitor M.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Alina","family":"Ferster","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Lutz","sequence":"additional","affiliation":[]},{"given":"Fran\u00e7oise","family":"Mazingue","sequence":"additional","affiliation":[]},{"given":"Dominique","family":"Plantaz","sequence":"additional","affiliation":[]},{"given":"Emmanuel","family":"Plouvier","sequence":"additional","affiliation":[]},{"given":"Yves","family":"Bertrand","sequence":"additional","affiliation":[]},{"given":"Yves","family":"Benoit","sequence":"additional","affiliation":[]},{"given":"Nicole","family":"Dastugue","sequence":"additional","affiliation":[]},{"given":"Pierre S.","family":"Rohrlich","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"issue":"15","key":"2515_CR1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"C-H Pui","year":"2004","unstructured":"Pui C-H, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350(15):1535\u20131548","journal-title":"N Engl J Med"},{"issue":"26","key":"2515_CR2","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1200\/JCO.2005.05.047","volume":"23","author":"SA Armstrong","year":"2005","unstructured":"Armstrong SA, Look AT (2005) Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 23(26):6306\u20136315","journal-title":"J Clin Oncol"},{"issue":"3","key":"2515_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2011.08957.x","volume":"156","author":"MD Kraszewska","year":"2012","unstructured":"Kraszewska MD, Dawidowska M, Szczepa\u0144ski T, Witt M (2012) T-cell acute lymphoblastic leukaemia: recent molecular biology findings. Br J Haematol 156(3):303\u2013315","journal-title":"Br J Haematol"},{"issue":"4","key":"2515_CR4","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1200\/JCO.1998.16.4.1270","volume":"16","author":"NA Heerema","year":"1998","unstructured":"Heerema NA, Sather HN, Sensel MG, Kraft P, Nachman JB, Steinherz PG et al (1998) Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group. J Clin Oncol 16(4):1270\u20131278","journal-title":"J Clin Oncol"},{"issue":"5","key":"2515_CR5","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood.V72.5.1560.1560","volume":"72","author":"SC Raimondi","year":"1988","unstructured":"Raimondi SC, Behm FG, Roberson PK, Pui CH, Rivera GK, Murphy SB et al (1988) Cytogenetics of childhood T-cell leukemia. Blood 72(5):1560\u20131566","journal-title":"Blood"},{"issue":"2","key":"2515_CR6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood.V78.2.466.466","volume":"78","author":"RC Ribeiro","year":"1991","unstructured":"Ribeiro RC, Raimondi SC, Behm FG, Cherrie J, Crist WM, Pui CH (1991) Clinical and biologic features of childhood T-cell leukemia with the t(11;14). Blood 78(2):466\u2013470","journal-title":"Blood"},{"issue":"7","key":"2515_CR7","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1182\/blood.V96.7.2543","volume":"96","author":"NR Schneider","year":"2000","unstructured":"Schneider NR, Carroll AJ, Shuster JJ, Pullen DJ, Link MP, Borowitz MJ et al (2000) New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood 96(7):2543\u20132549","journal-title":"Blood"},{"issue":"1","key":"2515_CR8","first-page":"10","volume":"7","author":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","year":"1993","unstructured":"Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique (1993) Collaborative study of karyotypes in childhood acute lymphoblastic leukemias. Leukemia 7(1):10\u201319","journal-title":"Leukemia"},{"issue":"10","key":"2515_CR9","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1073\/pnas.88.10.4367","volume":"88","author":"T Boehm","year":"1991","unstructured":"Boehm T, Foroni L, Kaneko Y, Perutz MF, Rabbitts TH (1991) The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci U S A 88(10):4367\u20134371","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2515_CR10","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1128\/MCB.9.5.2124","volume":"9","author":"EA McGuire","year":"1989","unstructured":"McGuire EA, Hockett RD, Pollock KM, Bartholdi MF, O\u2019Brien SJ, Korsmeyer SJ (1989) The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol 9(5):2124\u20132132","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2515_CR11","first-page":"349","volume":"4","author":"I S\u00e1nchez-Garc\u00eda","year":"1993","unstructured":"S\u00e1nchez-Garc\u00eda I, Rabbitts TH (1993) LIM domain proteins in leukaemia and development. Semin Cancer Biol 4(6):349\u2013358","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"2515_CR12","first-page":"1783","volume":"9","author":"MC Bene","year":"1995","unstructured":"Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A et al (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9(10):1783\u20131786","journal-title":"Leukemia"},{"issue":"12","key":"2515_CR13","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/leu.2010.205","volume":"24","author":"E Clappier","year":"2010","unstructured":"Clappier E, Collette S, Grardel N, Girard S, Suarez L, Brunie G et al (2010) NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia 24(12):2023\u20132031","journal-title":"Leukemia"},{"issue":"282","key":"2515_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53(282):457\u2013481","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"2515_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV et al (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35(1):1\u201339","journal-title":"Br J Cancer"},{"issue":"1","key":"2515_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood.V73.1.271.271","volume":"73","author":"FM Uckun","year":"1989","unstructured":"Uckun FM, Gajl-Peczalska KJ, Provisor AJ, Heerema NA (1989) Immunophenotype-karyotype associations in human acute lymphoblastic leukemia. Blood 73(1):271\u2013280","journal-title":"Blood"},{"issue":"1","key":"2515_CR17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0165-4608(95)00062-3","volume":"84","author":"IQ Zalcberg","year":"1995","unstructured":"Zalcberg IQ, Silva ML, Abdelhay E, Tabak DG, Ornellas MH, Sim\u00f5es FV et al (1995) Translocation 11;14 in three children with acute lymphoblastic leukemia of T-cell origin. Cancer Genet Cytogenet 84(1):32\u201338","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"2515_CR18","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1200\/JCO.1997.15.6.2214","volume":"15","author":"FM Uckun","year":"1997","unstructured":"Uckun FM, Gaynon PS, Sensel MG, Nachman J, Trigg ME, Steinherz PG et al (1997) Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children\u2019s Cancer Group study. J Clin Oncol 15(6):2214\u20132221","journal-title":"J Clin Oncol"},{"issue":"2","key":"2515_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D et al (2009) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 10(2):147\u2013156","journal-title":"Lancet Oncol"},{"issue":"5694","key":"2515_CR20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JP 4th, Silverman LB, Sanchez-Irizarry C et al (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306(5694):269\u2013271","journal-title":"Science"},{"issue":"2","key":"2515_CR21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood-2003-05-1495","volume":"103","author":"H Cav\u00e9","year":"2004","unstructured":"Cav\u00e9 H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A et al (2004) Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 103(2):442\u2013450","journal-title":"Blood"},{"issue":"7","key":"2515_CR22","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2007-04-079988","volume":"110","author":"J Bergeron","year":"2007","unstructured":"Bergeron J, Clappier E, Radford I, Buzyn A, Millien C, Soler G et al (2007) Prognostic and oncogenic relevance of TLX1\/HOX11 expression level in T-ALLs. Blood 110(7):2324\u20132330","journal-title":"Blood"},{"issue":"9408","key":"2515_CR23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(04)15542-6","volume":"363","author":"AA Ferrando","year":"2004","unstructured":"Ferrando AA, Neuberg DS, Dodge RK, Paietta E, Larson RA, Wiernik PH et al (2004) Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet 363(9408):535\u2013536","journal-title":"Lancet"},{"issue":"2","key":"2515_CR24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/leu.2009.253","volume":"24","author":"LB Silverman","year":"2010","unstructured":"Silverman LB, Stevenson KE, O\u2019Brien JE, Asselin BL, Barr RD, Clavell L et al (2010) Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985\u20132000). Leukemia 24(2):320\u2013334","journal-title":"Leukemia"},{"issue":"3","key":"2515_CR25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","volume":"13","author":"MD Amylon","year":"1999","unstructured":"Amylon MD, Shuster J, Pullen J, Berard C, Link MP, Wharam M et al (1999) Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia 13(3):335\u2013342","journal-title":"Leukemia"},{"issue":"8","key":"2515_CR26","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood.V99.8.2734","volume":"99","author":"M Duval","year":"2002","unstructured":"Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P et al (2002) Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children\u2019s Leukemia Group phase 3 trial. Blood 99(8):2734\u20132739","journal-title":"Blood"},{"issue":"5","key":"2515_CR27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2141.2010.08192.x","volume":"149","author":"JL McNeer","year":"2010","unstructured":"McNeer JL, Nachman JB (2010) The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers. Br J Haematol 149(5):638\u2013652","journal-title":"Br J Haematol"},{"issue":"4","key":"2515_CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/mpo.2950190411","volume":"19","author":"B Jones","year":"1991","unstructured":"Jones B, Freeman AI, Shuster JJ, Jacquillat C, Weil M, Pochedly C et al (1991) Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. Med Pediatr Oncol 19(4):269\u2013275","journal-title":"Med Pediatr Oncol"},{"issue":"6","key":"2515_CR29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1365-2141.2005.05509.x","volume":"129","author":"CD Mitchell","year":"2005","unstructured":"Mitchell CD, Richards SM, Kinsey SE, Lilleyman J, Vora A, Eden TOB (2005) Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol 129(6):734\u2013745","journal-title":"Br J Haematol"},{"issue":"11","key":"2515_CR30","first-page":"7","volume":"112","author":"M Schrappe","year":"2008","unstructured":"Schrappe M, Zimmerman M, Moricke A, Mann G, Valsecchi MG, Bartram CR et al (2008) Dexamethasone in induction can eliminate one-third of all relapses in childhood acute lymphoblastic leukemia (ALL): results of an international randomised trial in 3655 patients (trial AIEOP-BFM ALL 2000). ASH Annu Meeting Abstr 112(11):7","journal-title":"ASH Annu Meeting Abstr"},{"issue":"27","key":"2515_CR31","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1200\/JCO.2005.01.982","volume":"23","author":"S Igarashi","year":"2005","unstructured":"Igarashi S, Manabe A, Ohara A, Kumagai M, Saito T, Okimoto Y et al (2005) No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children\u2019s Cancer Study Group L95-14 protocol. J Clin Oncol 23(27):6489\u20136498","journal-title":"J Clin Oncol"},{"issue":"3","key":"2515_CR32","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1200\/JCO.1998.16.3.920","volume":"16","author":"J Nachman","year":"1998","unstructured":"Nachman J, Sather HN, Cherlow JM, Sensel MG, Gaynon PS, Lukens JN et al (1998) Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children\u2019s Cancer Group. J Clin Oncol 16(3):920\u2013930","journal-title":"J Clin Oncol"},{"issue":"4","key":"2515_CR33","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2010-06-292615","volume":"118","author":"BL Asselin","year":"2011","unstructured":"Asselin BL, Devidas M, Wang C, Pullen J, Borowitz MJ, Hutchison R et al (2011) Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children\u2019s Oncology Group (POG 9404). Blood 118(4):874\u2013883","journal-title":"Blood"},{"issue":"12","key":"2515_CR34","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1200\/JCO.2010.30.2877","volume":"29","author":"T Szczepanski","year":"2011","unstructured":"Szczepanski T, van der Velden VHJ, Waanders E, Kuiper RP, Van Vlierberghe P, Gruhn B et al (2011) Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition. J Clin Oncol 29(12):1643\u20131649","journal-title":"J Clin Oncol"},{"issue":"9","key":"2515_CR35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","volume":"339","author":"H Cav\u00e9","year":"1998","unstructured":"Cav\u00e9 H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J et al (1998) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer\u2014Childhood Leukemia Cooperative Group. N Engl J Med 339(9):591\u2013598","journal-title":"N Engl J Med"},{"issue":"8","key":"2515_CR36","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2011-03-338707","volume":"118","author":"M Schrappe","year":"2011","unstructured":"Schrappe M, Valsecchi MG, Bartram CR, Schrauder A, Panzer-Gr\u00fcmayer R, M\u00f6ricke A et al (2011) Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood 118(8):2077\u20132084","journal-title":"Blood"},{"issue":"36","key":"2515_CR37","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1200\/JCO.2006.06.2679","volume":"24","author":"A Schrauder","year":"2006","unstructured":"Schrauder A, Reiter A, Gadner H, Niethammer D, Klingebiel T, Kremens B et al (2006) Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. J Clin Oncol 24(36):5742\u20135749","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2515-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2515-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2515-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T14:27:03Z","timestamp":1599661623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2515-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2515"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2515-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2015,10,12]]}}}